台股 » 個股 » 神隆 » 籌碼相關 » 券商分點績效

神隆

(1789)
可現股當沖
  • 股價
    28.20
  • 漲跌
    ▲0.25
  • 漲幅
    +0.89%
  • 成交量
    847
  • 產業
    上市 生技醫療類股
  • 300人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
神隆 (1789)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/04/24     後一日»

券商獲利排行 - 2024/04/24

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  0.95%36.720.316.4481389027.927.928.128.2
  0.91%9.54.64.91737202827.928.128.2
  1.33%9.309.32525027.827.8028.2
  1.17%8.508.52626027.927.9028.2
  0.68%80.57.52942132827.92828.2
  1.01%7.1072325227.927.927.928.2
  0.97%6.806.82525027.927.9028.2
  0.97%6.8-0.16.92325227.927.927.928.2
  0.57%5.35.300333327.927.82828.2
  1.24%5.21.93.3101552827.928.328.2
  0.89%505202002828028.2
  1.20%5051515027.927.9028.2
  1.04%4.704.71616027.927.9028.2
  0.47%4.404.412332127.827.827.828.2
  0.98%4.104.11515027.927.9028.2
  0.89%3.803.8151502828028.2
  1.08%3.603.61212027.927.9028.2
  1.74%2.902.966027.727.7028.2
  1.44%2.802.877027.827.8028.2
  1.59%2.702.766027.827.8028.2
  0.89%2.502.5101002828028.2
  1.26%2.502.577027.927.9028.2
  1.08%2.402.488027.927.9028.2
  1.44%2.402.466027.827.8028.2
  0.67%2.302.3121202828028.2
  0.71%202101002828028.2
  1.20%20266027.927.9028.2
  1.44%20255027.827.8028.2
  1.44%20255027.827.8028.2
  1.44%20255027.827.8028.2
  0.87%2028802828028.2
  1.26%1.801.855027.927.9028.2
  0.68%1.701.759327.927.927.928.2
  0.55%1.701.7111102828028.2
  1.18%1.701.755027.927.9028.2
  1.15%1.601.655027.927.9028.2
  1.39%1.601.644027.827.8028.2
  1.11%1.60.31.245127.927.928.228.2
  0.53%1.501.51010028.128.1028.2
  1.08%1.501.555027.927.9028.2
  1.08%1.501.555027.927.9028.2
  1.08%1.501.555027.927.9028.2
  1.04%1.401.455027.927.9028.2
  0.97%1.401.455027.927.9028.2
  1.21%1.401.444027.927.9028.2
  0.93%1.301.355027.927.9028.2
  0.93%1.301.355027.927.9028.2
  1.17%1.301.344027.927.9028.2
  1.50%1.30.80.513227.927.728.128.2
  1.11%1.20.30.924127.927.928.228.2

券商虧損排行 - 2024/04/24

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -1.42%-78.90-78.9-200020027.8027.828.2
  -1.59%-12.40-12.4-2802827.8027.828.2
  -1.26%-8.80-8.8-2502527.9027.928.2
  -0.89%-7.50-7.5-300302802828.2
  -1.31%-7.30-7.3-2002027.8027.828.2
  -1.18%-6.30-6.3-1901927.9027.928.2
  -1.05%-5.90.1-5.9-1912027.927.827.928.2
  -1.06%-5.10-5.1-1601727.92827.928.2
  -0.57%-50.5-5.5-247312827.92828.2
  -1.49%-4.60-4.6-1101127.8027.828.2
  -0.74%-4.10.4-4.6-1362027.927.827.928.2
  -1.62%-4.10-4.1-90927.8027.828.2
  -1.08%-3.60-3.6-1201227.9027.928.2
  -1.09%-3.40-3.4-1101127.9027.928.2
  -1.18%-3.30-3.3-1001027.9027.928.2
  -0.27%-2.80-2.8-8273627.927.927.928.2
  -1.08%-2.70-2.7-90927.9027.928.2
  -0.89%-2.50-2.5-100102802828.2
  -1.81%-2.50-2.5-40527.727.827.728.2
  -0.80%-2.50.1-2.5-1011127.927.92828.2
  -1.62%-2.30-2.3-50527.8027.828.2
  -1.10%-2.20-2.2-70727.9027.928.2
  -0.71%-20-2-100102802828.2
  -1.08%-1.80-1.8-60627.9027.928.2
  -0.82%-1.60-1.6-7072802828.2
  -0.92%-1.60-1.6-60627.9027.928.2
  -1.11%-1.6-0.4-1.2-4152828.327.928.2
  -1.81%-1.50-1.5-30327.7027.728.2
  -0.87%-1.50-1.4-42627.927.927.928.2
  -1.00%-1.40-1.4-50527.9027.928.2
  -1.26%-1.40-1.4-40427.9027.928.2
  -1.17%-1.30-1.3-40427.9027.928.2
  -0.89%-1.30-1.3-5052802828.2
  -1.49%-1.3-0.8-0.4-1232828.227.828.2
  -1.27%-1.10-1.1-30327.8027.828.2
  -1.26%-1.10-1.1-30327.9027.928.2
  -1.19%-1-1003328.128.227.928.2
  -0.17%-0.9-0.900202027.927.927.928.2
  -1.08%-0.90-0.9-30327.9027.928.2
  -1.07%-0.9-0.3-0.6-2132828.227.928.2
  -0.71%-0.80-0.8-4042802828.2
  -1.44%-0.80-0.8-20227.8027.828.2
  -0.89%-0.80-0.8-3032802828.2
  -1.35%-0.80-0.8-20227.8027.828.2
  -0.50%-0.70-0.7-50528.1028.128.2
  -1.26%-0.70-0.7-20227.9027.928.2
  -1.26%-0.70-0.7-20227.9027.928.2
  -1.26%-0.70-0.7-20227.9027.928.2
  -1.26%-0.70-0.7-20227.9027.928.2
  -1.26%-0.70-0.7-20227.9027.928.2
逸達前列腺癌新藥獲美藥證 神隆同步受惠Anue鉅亨-2021/05/27
〈神隆法說〉上游原物料漲幅過大 部分產品將啟動漲價Anue鉅亨-2021/05/26
〈神隆法說〉常熟廠代客研製新藥下半年放量 營運可望改善Anue鉅亨-2021/05/26
神隆 相關文章